4-Chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine
95%
- Product Code: 47206
CAS:
91862-35-0
| Molecular Weight: | 167.5956 g./mol | Molecular Formula: | C₇H₆ClN₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD17013038 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. It serves as a building block for the development of potential therapeutic agents, particularly in the design of kinase inhibitors. These inhibitors are crucial for targeting specific enzymes involved in cell signaling pathways, making them valuable in the treatment of diseases such as cancer and inflammatory disorders. Additionally, its structural framework is explored in the creation of compounds with potential antiviral and antibacterial properties, contributing to ongoing research in infectious disease management. Its versatility in chemical modifications allows for the optimization of drug candidates for enhanced efficacy and selectivity.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | £124.98 |
+
-
|
4-Chloro-6-methyl-5H-pyrrolo[3,2-d]pyrimidine
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active molecules. It serves as a building block for the development of potential therapeutic agents, particularly in the design of kinase inhibitors. These inhibitors are crucial for targeting specific enzymes involved in cell signaling pathways, making them valuable in the treatment of diseases such as cancer and inflammatory disorders. Additionally, its structural framework is explored in the creation of compounds with potential antiviral and antibacterial properties, contributing to ongoing research in infectious disease management. Its versatility in chemical modifications allows for the optimization of drug candidates for enhanced efficacy and selectivity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :